RX Healthcare finalizes Al Mottahedoon Pharma acquisition

M&A WATCH- Rx Healthcare Fund finalizes Al Mottahedoon Pharma acquisition: EFG Hermes’ Rx Healthcare Fund has finalized its acquisition of an 80% stake in meds producer Al Mottahedoon Pharma, according to Al Mal. The fund purchased shares from individual investors, the newspaper says, without providing further details. The value of the transaction was not disclosed, but local press reports from earlier this year had suggested it would cost Rx somewhere around EGP 360 mn.

Advisors: ARC Capital acted as financial advisor on the transaction, while our friends at ALC were legal counsel to the sellers.